[LGND] YoY Quarter Result on 30-Jun-2017 [#Q2]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
08-Aug-2017
Financial Year
2017
Quarter
30-Jun-2017 [#Q2]
Profit Trend
QoQ- 19.28%
YoY- 205.12%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Quarter Result
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
Revenue 41,420 24,987 90,043 27,995 19,521 18,418 10,608 25.46%
PBT 28,119 -18,028 95,579 8,300 -9,644 22,292 1,241 68.13%
Tax 6,033 -3,609 22,419 2,242 -3,881 265 -47 -
NP 22,086 -14,419 73,160 6,058 -5,763 23,564 1,592 54.94%
Tax Rate -21.46% - -23.46% -27.01% - -1.19% 3.79% -
Total Cost 19,334 39,406 16,883 21,937 25,284 -5,146 9,016 13.54%
Ratio Analysis
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
NP Margin 53.32 -57.71 81.25 21.64 -29.52 127.94 15.01 23.50%
Per Share
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
EPS 1.38 -0.74 3.45 0.29 -0.28 1.19 0.08 60.67%
EPS Diluted 1.32 -0.74 2.99 0.26 -0.28 1.11 0.07 63.07%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.